JP Morgan Chase’s Quipt Home Medical QIPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-66
| Closed | -$233 | – | 7819 |
|
|
2025
Q4 | $233 | Sell |
66
-700
| -91% | -$1.85K | ﹤0.01% | 7145 |
|
|
2025
Q3 | $2K | Hold |
766
| – | – | ﹤0.01% | 6918 |
|
|
2025
Q2 | $1.37K | Sell |
766
-49,759
| -98% | -$98.2K | ﹤0.01% | 6585 |
|
|
2025
Q1 | $118K | Sell |
50,525
-53,228
| -51% | -$146K | ﹤0.01% | 5486 |
|
|
2024
Q4 | $316K | Buy |
103,753
+73,350
| +241% | +$197K | ﹤0.01% | 5274 |
|
|
2024
Q3 | $88.8K | Buy |
30,403
+12,383
| +69% | +$38.2K | ﹤0.01% | 5750 |
|
|
2024
Q2 | $58K | Sell |
18,020
-31,603
| -64% | -$113K | ﹤0.01% | 5793 |
|
|
2024
Q1 | $217K | Buy |
49,623
+22,224
| +81% | +$100K | ﹤0.01% | 5306 |
|
|
2023
Q4 | $139K | Buy |
27,399
+13
| +0% | +$62 | ﹤0.01% | 5585 |
|
|
2023
Q3 | $139K | Sell |
27,386
-3,903
| -12% | -$20.9K | ﹤0.01% | 5288 |
|
|
2023
Q2 | $167K | Buy |
+31,289
| New | +$185K | ﹤0.01% | 5178 |
|
|
2021
Q4 | – | Sell |
-5,724
| Closed | -$36K | – | 6904 |
|
|
2021
Q3 | $36K | Sell |
5,724
-25,126
| -81% | -$151K | ﹤0.01% | 5917 |
|
|
2021
Q2 | $210K | Buy |
+30,850
| New | +$189K | ﹤0.01% | 5223 |
|
JP Morgan Chase's QIPT Position: Q1 2026 in Review
JP Morgan Chase sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 66 shares — an estimated $233 sold.
JP Morgan Chase first reported a position in QIPT in Q2 2021 and held it in 13 quarters. The position peaked at $316K in Q4 2024. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.
- JP Morgan Chase reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
- JP Morgan Chase sold 66 Quipt Home Medical shares in Q1 2026, an estimated $233.
- JP Morgan Chase first reported a position in Quipt Home Medical in Q2 2021 and held it in 13 quarters.
- JP Morgan Chase's Quipt Home Medical position peaked at $316K in Q4 2024.
- 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.